Recite me link

1. How many gynaecologists within your organisation perform laparoscopic procedures requiring morcellation?
2. How many power morcellators do you purchase per annum for gynaecology?
3. How many power morcellators do you use in gynaecology per annum?
4. How many laparoscopic hysterectomies requiring morcellation do you perform annually?
5. How many laparoscopic myomectomies requiring morcellation do you perform annually?
6. For patients requiring morcellation, do you routinely perform pre-operative MRI?
7. For patients requiring morcellation, do you routinely perform pre-operative endometrial sampling/biopsy?
8. During the consent process, do you specifically consent for power morcellation in gynaecology?
9. During the consent process, what risk of inadvertent leiomyosarcoma do you quote during hysterectomies/myomectomies for benign fibroids?
10. During the consent process, what risks do you quote for spread of inadvertent leiomyosarcoma from power morcellation?
11. Has your organisation ever encountered inadvertent leiomyosarcoma following hysterectomy or myomectomy for presumed benign indications? If so, many?
12. Do you have information leaflet about morcellation in gynaecology?
13. What audit procedures do you have in place for gynaecologists participating in power morcellation?

Download response Gynaecology. 210519